LATEST TWEETS - CURATED BY HASH FINANCE

Amneal Pharmaceuticals Inc $AMRX Forecasted to Earn Q3 2020 Earnings of $0.13 Per Share https://t.co/pACaMdmklp
Amneal Pharmaceuticals $AMRX Stock Rating Lowered by Svb Leerink https://t.co/fuA0XsE7I0
Amneal Pharmaceuticals $AMRX PT Lowered to $4.00 at Raymond James https://t.co/DQqPAhZflg
Amneal Pharmaceuticals Inc $AMRX Forecasted to Post Q3 2020 Earnings of $0.13 Per Share https://t.co/PCkJY0rzpw #stocks
SunTrust Banks Sets Amneal Pharmaceuticals Q3 2020 Earnings Estimates at $0.13 EPS. https://t.co/6Nb8QtGNT9 $AMRX #AMRX
Amneal Pharmaceuticals Inc to Post Q1 2020 Earnings of $0.06 Per Share, Piper Jaffray Companies Forecasts $AMRX https://t.co/3wmjSiEfpW
Amneal Pharmaceuticals Inc to Post Q1 2020 Earnings of $0.06 Per Share, Piper Jaffray Companies Forecasts $AMRX https://t.co/qMRpnYOnfA
Piper Jaffray Companies Lowers Amneal Pharmaceuticals Q1 2020 Earnings Estimates to $0.06 EPS (Previously $0.11).… https://t.co/V0ZpJr3kb3
Amneal Pharmaceuticals $AMRX Lowered to “Market Perform” at Svb Leerink https://t.co/kTnlQ8aT8e
Svb Leerink Lowers Amneal Pharmaceuticals $AMRX to Market Perform https://t.co/8U4GLm73Wq
Amneal Pharmaceuticals $AMRX Downgraded to “Market Perform” at Leerink Swann https://t.co/BAotir2J6A
Amneal Pharmaceuticals $AMRX Downgraded by Leerink Swann https://t.co/mv8Lux5NPq
Raymond James Trims Amneal Pharmaceuticals $AMRX Target Price to $4.00 https://t.co/OxWJ8UkA0H
Amneal Pharmaceuticals $AMRX Price Target Cut to $4.00 https://t.co/czIi4PlNJl
$AMRX I'll have my bear burger medium rare with mushroom and swiss please. 3.02 % change recently https://t.co/NO8POEKv7x
Svb Leerink Downgrades Amneal Pharmaceuticals $AMRX to Market Perform https://t.co/wtxyAM2f9F
Amneal Pharmaceuticals $AMRX PT Lowered to $4.00 https://t.co/Veo4Md52UY
Amneal Pharmaceuticals $AMRX Lowered to Market Perform at Svb Leerink https://t.co/6mPvlWgnWO
Amneal Pharmaceuticals $AMRX Downgraded by Leerink Swann to “Market Perform” https://t.co/17XrcyeZDs
Amneal Pharmaceuticals $AMRX Price Target Lowered to $4.00 at Raymond James https://t.co/rJJx5jdWJu
Amneal Pharmaceuticals $AMRX Rating Lowered to Market Perform at Leerink Swann https://t.co/PBHpZ9bQbb
Svb Leerink Lowers Amneal Pharmaceuticals $AMRX to Market Perform https://t.co/mhoT6PfGwA
Amneal Pharmaceuticals $AMRX Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS https://t.co/MlfVUwSj77
Amneal Pharmaceuticals $AMRX Posts Earnings Results, Misses Estimates By $0.09 EPS https://t.co/2XgoPlKgK9
Amneal Pharmaceuticals $AMRX Shares Gap Down After Earnings Miss https://t.co/vdEtVKlxYq
sun (sunshineavenue8) 3 days ago
short ratio of $AMRX is 4.16 at 2019-05-31 https://t.co/zlwgv1ILnp